Fatty acids that selectively kill senescent cells open new paths for age-related therapies
Alex Smith, University of Minnesota Medical School
March 12, 2026 (Medical Xpress) — New research from the University of Minnesota Medical School has identified fatty acids that selectively induce death in senescent cells—the culprits behind aging and many chronic diseases—opening new avenues for age-related therapies. The findings are published in Cell Press Blue.
The research team discovered certain naturally occurring polyunsaturated lipids can selectively remove senescent cells. Senescent cells are old, damaged cells that accumulate with age and contribute to aging and many age-related diseases like pulmonary fibrosis, osteoarthritis and loss of resilience to infections.
These lipids cause senescent cells to die through a process called ferroptosis, which is a regulated form of cell death that occurs when iron in the cell triggers damaging reactions in its fats. The study also showed that these aging cells have high levels of iron and oxidative stress, which makes them uniquely susceptible to this process. Since lowering the number of senescent cells is associated with better health in old age, these natural, active fats could be used as a treatment for age-related illnesses caused by cellular senescence.
“This paper is the first to show that lipids can function as senolytics by triggering a distinct form of cell death, called ferroptosis, unlike most current senolytic strategies,” said Paul Robbins, Ph.D., professor at the University of Minnesota Medical School and College of Biological Sciences, and associate director of the Masonic Institute on the Biology of Aging and Metabolism.
“Our study reveals that ferroptosis represents a distinct and targetable vulnerability in certain types of senescent cells. Thus, this work opens a new direction for designing senolytic therapies that leverage ferroptotic biology and demonstrates the therapeutic potential of specific bioactive fatty acids.”
Future research will focus on expanding in vivo studies beyond preclinical models and moving toward early clinical evaluation to determine whether reducing senescent cell burden with these lipids can improve health outcomes in certain age-related diseases.
Publication details
Lei Justan Zhang et al, Polyunsaturated lipid senolytics exploit a ferroptotic vulnerability in senescent cells, Cell Press Blue (2026). DOI: 10.1016/j.cpblue.2026.100004
Journal information: Cell Press Blue